Vaxart, Inc. Balance Sheet
VXRT|13 years of annual SEC 10-K data (FY2009-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 13 fiscal years. All figures from audited SEC 10-K filings.
Vaxart, Inc. had $186M in total assets and $88M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.04 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $63.8M | - | - | $11.5M | $1.6M | $8.4M | $44.7M | $81.7M | $66.8M | $53.8M | $74.2M | $53.6M | - |
| Accounts Receivable | $14.6M | $5.8M | $3.0M | $1.8M | $630.0K | $700.0K | $12.6M | $18.7M | $11.0M | - | - | - | - |
| Current Assets | $136.1M | $68.3M | $45.5M | $14.6M | $3.8M | $72.4M | $70.8M | $101.1M | $80.0M | - | $97.9M | - | - |
| PP&E (Net) | $5.4M | $8.7M | $11.7M | $1.1M | $730.0K | $300.0K | $200.0K | $2.0M | $4.3M | - | $84.0K | - | - |
| Goodwill | $4.5M | $4.5M | $4.5M | - | - | - | - | - | - | - | - | - | - |
| Total Assets | $186.1M | $166.4M | $91.8M | $35.2M | $4.5M | $72.7M | $79.4M | $114.0M | $85.8M | - | $98.0M | - | - |
| Current Liabilities | $86.8M | $90.9M | $13.7M | $7.5M | $4.5M | $9.2M | $9.0M | $26.9M | $17.6M | - | $6.3M | - | - |
| Total Debt | - | - | - | $17.7M | $15.9M | - | - | - | - | - | - | - | - |
| Shareholders' Equity | $87.8M | $58.9M | $57.8M | $11.2M | -$38.7M | -$29.6M | $69.5M | $86.9M | $68.0M | $59.3M | $81.4M | - | - |